Utpal Koppikar insider trades
Open-market stock purchases and sales by Utpal Koppikar, Director at C4 Therapeutics, Inc, from SEC Form 4 filings since Jun 7, 2018.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -52%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | CCCC C4 Therapeutics, Inc | Bought (not open market) | — |